ArticleAntibiotics (Basel, Switzerland)2017

Bulgecin A: The Key to a Broad-Spectrum Inhibitor  That Targets Lytic Transglycosylases.

Allison H Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.